Marshall Wace, LLP Care Dx, Inc. Transaction History

Marshall Wace, LLP

$77.3 Billion
Q3 2024

A detailed history of Marshall Wace, LLP transactions in Care Dx, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 368,430 shares of CDNA stock, worth $8.59 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

368,430

Previous 55,711 561.32%

Holding current value

$8.59 Million

Previous $865,000 1229.71%

% of portfolio

0.01%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$14.41 - $33.99 $4.51 Million - $10.6 Million	312,719 Added 561.32%	368,430 $11.5 Million
Q2 2024 Aug 14, 2024	SELL	$7.56 - $16.15 $1.6 Million - $3.41 Million	-211,002 Reduced 79.11%	55,711 $865,000
Q1 2024 May 15, 2024	BUY	$7.96 - $12.37 $1.76 Million - $2.74 Million	221,451 Added 489.26%	266,713 $2.82 Million
Q4 2023 Feb 14, 2024	BUY	$4.9 - $12.86 $58,231 - $152,828	11,884 Added 35.6%	45,262 $543,000
Q3 2023 Nov 14, 2023	SELL	$7.0 - $11.26 $829,262 - $1.33 Million	-118,466 Reduced 78.02%	33,378 $233,000
Q2 2023 Aug 14, 2023	SELL	$7.61 - $9.46 $3.71 Million - $4.61 Million	-487,413 Reduced 76.25%	151,844 $1.29 Million
Q1 2023 May 15, 2023	BUY	$8.83 - $17.61 $5.64 Million - $11.3 Million	639,257 New	639,257 $5.84 Million
Q1 2022 May 16, 2022	SELL	$28.19 - $46.6 $36,195 - $59,834	-1,284 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$41.2 - $73.6 $160,226 - $286,230	-3,889 Reduced 75.18%	1,284 $58,000
Q3 2021 Nov 15, 2021	BUY	$59.15 - $91.99 $140,599 - $218,660	2,377 Added 85.01%	5,173 $328,000
Q2 2021 Aug 13, 2021	SELL	$63.02 - $95.11 $2.27 Million - $3.42 Million	-36,005 Reduced 92.79%	2,796 $256,000
Q1 2021 May 17, 2021	BUY	$57.62 - $95.6 $2.24 Million - $3.71 Million	38,801 New	38,801 $2.64 Million
Q4 2020 Feb 16, 2021	SELL	$41.43 - $77.09 $297,301 - $553,197	-7,176 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$30.88 - $37.94 $221,594 - $272,257	7,176 New	7,176 $273,000
Q1 2020 May 15, 2020	SELL	$13.94 - $28.25 $320,633 - $649,778	-23,001 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$19.24 - $28.41 $442,539 - $653,458	23,001 New	23,001 $496,000
Q3 2019 Nov 14, 2019	SELL	$20.03 - $40.08 $139,549 - $279,237	-6,967 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$25.78 - $39.77 $179,609 - $277,077	6,967 New	6,967 $250,000
Q1 2019 May 14, 2019	SELL	$22.09 - $39.21 $1.24 Million - $2.19 Million	-55,918 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$19.89 - $30.02 $1.11 Million - $1.68 Million	55,918 New	55,918 $1.41 Million

Others Institutions Holding CDNA

# of Institutions

218

Shares Held

50.4M

Call Options Held

97.3K

Put Options Held

43.3K

View Full List

About CareDx, Inc.

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $1.25B
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

More about CDNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Care Dx, Inc. Transaction History